Patient involvement in clinical trials

Jan Geißler1, Emily Isham2, Gary Hickey3,4

  • 1The Patvocates Network, Munich, Germany.

Insights

Patient and community involvement in clinical trials ensures new treatments are safe and effective. Engaging participants in trial planning and execution benefits both the study and the community.

Area of Science:

  • Clinical research methodology
  • Patient engagement in healthcare

Background:

  • Clinical trials are essential for validating the safety and efficacy of novel medical treatments.
  • Participant involvement is increasingly recognized as vital for successful clinical research.

Purpose of the Study:

  • To highlight the critical role of participant involvement in clinical trial success.
  • To emphasize the importance of community benefit derived from clinical trials.

Main Methods:

  • Review of best practices in patient-centered clinical trial design.
  • Analysis of case studies demonstrating successful participant engagement.

Main Results:

  • Participant involvement enhances trial relevance and adherence.
  • Community engagement fosters trust and facilitates recruitment.

Conclusions:

  • Integrating participants into trial planning and execution is paramount.
  • Active participant and community involvement leads to more effective and beneficial clinical research outcomes.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
7.0K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
165
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K